<DOC>
	<DOCNO>NCT02405416</DOCNO>
	<brief_summary>This clinical trial aim compare infrahepatic inferior vena cava clamping ( IIVCC ) selective hepatic vascular exclusion ( SHVE ) involve portal triad clamping ( PTC ) complex cirrhotic liver resection . One group receive IIVCC plus PTC , another equivalent group patient operate use SHVE PTC .</brief_summary>
	<brief_title>Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving Portal Triad Clamping</brief_title>
	<detailed_description>Intraoperative blood loss significantly associate clinical outcome patient undergo hepatectomy . There various hepatic vascular control technique , include infrahepatic inferior vena cava clamping ( IIVCC ) selective hepatic vascular exclusion ( SHVE ) .The propose study compare two surgical technique combine portal triad clamping ( PTC ) hepatic cirrhotic patient . All patient perform hepatectomy center scan accord inclusion exclusion criterion . After intraoperative exploration , patient randomize two interventional group . PTC , IIVCC SHVE perform specify timepoint liver parenchymal transection two different group . All data collect prospectively .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1. either male female , old 18 ( include 18 ) . 2. tumor oppress close proximity one major hepatic vein . 3. maximum diameter tumor ≥ 5cm , number lesion ≤ 3 liver lobe multiple lesion exit . 4. preoperative liver function assessment : ChildPugh classification A B . 5. preoperative laboratory test : blood platlet count ＞ 100×10^9/l , prothrombin activity ＞ 60 % . 6. liver cirrhosis . 1. contraindication surgery , e.g.severe disorder circulation , respiratory renal system . 2. extrahepatic metastasis patient malignancy tumor invasion portal vein , hepatic vein , bile duct inferior vena cava . 3. hepatectomy accompanied organ resection ( e.g . bile duct , intestine , pancreas stomach ) 4. regular hepatectomy . 5. tumor locate leave lateral lobe liver . 6. previous hepatectomy . 7. pregnancy lactation . 8. refusal participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hepatocellular Carcinoma</keyword>
	<keyword>Blood Loss</keyword>
	<keyword>Haemorrhage</keyword>
	<keyword>Vascular Control</keyword>
</DOC>